Literature DB >> 6455127

In vitro regulation of immunoglobulin synthesis after marrow transplantation. I. T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease.

L G Lum, M C Seigneuret, R F Storb, R P Witherspoon, E D Thomas.   

Abstract

Twenty-four patients with aplastic anemia or acute leukemia were treated by marrow grafts from HLA-identical donors after conditioning with high doses of cyclophosphamide and/or today body irradiation. They were studied between 4 and 63 mo (median 14.2) after transplantation. Seventeen patients had chronic graft-versus-host disease (C-GVHD) and 7 were healthy. They were studied for defects in their T- and B-cell function using and indirect hemolytic plaque assay for Ig production after 6 days of culture in the presence of pokeweek mitogen. T or B cells from the patients with or without C-GVHD were cocultured with T or B cells from their HLA-identical marrow donors or unrelated normal controls. Intrinsic B-cell defects, lack of helper T-cell activity, and suppressor T-cell activity were more frequently found in patients with C-GVHD than in healthy patients. Fifteen of the 17 patients with C-GVHD showed on or more defects in their T-and B-cell function compared to only 3 of the 7 patients without C-GVHD. None of the healthy controls, including the marrow donors, showed defects in their T- and B-cell functions. These in vitro findings may be helpful in assessing the process of immune reconstitution and the immunologic aberration found after human marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6455127

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

Review 1.  Management of graft-versus-host disease in paediatric bone marrow transplant recipients.

Authors:  M Zecca; F Locatelli
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

2.  Total and allergen-specific IgE in relation to allergic response pattern following bone marrow transplantation.

Authors:  S A Walker; P G Riches; G Wild; A M Ward; P J Shaw; S Desai; J R Hobbs
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

3.  Clinical significance of nontuberculous mycobacteria from respiratory specimens in stem cell transplantation recipients.

Authors:  Ji Young Kang; Jick Hwan Ha; Hye Seon Kang; Hyoung-Kyu Yoon; Hee-Je Kim; Seok Lee; Dong-Gun Lee; Jung Im Jung; Seok Chan Kim; Young Kyoon Kim
Journal:  Int J Hematol       Date:  2015-02-08       Impact factor: 2.490

4.  The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients.

Authors:  L G Lum; M C Seigneuret; R Storb
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

5.  Natural killer cell activity against a thymoma cell line Thy 121 in bone marrow transplant recipients.

Authors:  E Heidemann; H Schmidt; K Schüch; P Ostendorf; H D Waller
Journal:  Klin Wochenschr       Date:  1986-02-03

6.  Serum immunoglobulin levels following allogeneic bone marrow transplantation.

Authors:  C Perreault; M Giasson; M Gyger; R Belanger; M David; Y Bonny; J Boileau; R Barcelo; J P Moquin
Journal:  Blut       Date:  1985-09

7.  Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part II: Late post-transplant period.

Authors:  S A Walker; P G Riches; T R Rogers; S White; J R Hobbs
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

Review 8.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

Authors:  Juan Gea-Banacloche; Krishna V Komanduri; Paul Carpenter; Sophie Paczesny; Stefanie Sarantopoulos; Jo-Anne Young; Nahed El Kassar; Robert Q Le; Kirk R Schultz; Linda M Griffith; Bipin N Savani; John R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-14       Impact factor: 5.742

9.  Ceftazidime does not enhance cyclosporin-A nephrotoxicity in febrile bone marrow transplantation patients.

Authors:  C Verhagen; B E de Pauw; T de Witte; R S Holdrinet; J T Janssen; K J Williams
Journal:  Blut       Date:  1986-10

10.  Bone marrow transplantation in man. Analysis of T and B cell functions in PWM driven Ig production.

Authors:  H C Rümke; F G Terpstra; M T Roos; J M Vossen; L J Dooren; P T Schellekens; W P Zeijlemaker
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.